Veeva Systems

Veeva Systems was founded in 2007, and immediately engaged with Barbadora INK. The company is now public and on pace to hit $5 billion in revenue before 2020, ranking as one of the fastest growing cloud software companies of all time. For more than a decade, Barbadora INK has led the company’s global public relations efforts through its IPO, first product launch through to its 20+ product launch. Barbadora INK has handled business press opportunities, technology trades, and the global life sciences industry media where Lisa spends most of her time today for Veeva.

Contributing to Rapid Growth

Barbadora INK has written hundreds of press releases, blog entries, case studies, white papers, and byline feature articles and served as the strategic brainpower behind the organizations rich and rapidly growing media outreach efforts. We helped the organization grow from just 5 employees to a 500-person global technology company. In Fiscal Year 2017, Barbadora INK secured more than 160 interviews, and 35 byline feature articles in key trade publications for a total of 2.14 billion audience impressions. We helped launch three new products and coordinated extensive media programs at two major industry events that brought 1500+ industry leaders together. Below are some highlights:

Project Highlights

• Pharmaceutical Executive: Digital Disruption is Coming: Are You Ready?
  Read Live
• FierceBiotech: Novartis, Pfizer join with Big Biopharma peers to create tech standards that streamline how HCPs access info
  Read Live
• FiercePharma: Pharma's latest idea for getting drug info in front of docs? Give them a single login
  Read Live
• Contract Pharma: GSK Adds Veeva Commercial Cloud
  Read Live
• Pharmaceutical Commerce: A conversation with Matt Wallach
  Read Live
• Pharma VOICE: The Specialty Drug Market
  Read Live

Byline Features

In Fiscal Year 2018, Barbadora INK secured 90 byline feature articles (versus 35 the previous year) and 175 media interviews (versus 160 the previous year).

Most recently in Fiscal Year 2019, Barbadora INK secured 152 byline feature articles (versus 90 the previous year) and 205 media interviews (versus 175 the previous year) for a total of 3.2 billion audience impressions – the largest number to date. We also did a virtual media tour to introduce a new executive and secured interviews with 80% of the targeted publications.

• Pharma Tech Outlook: The Missing Link for AI in Life Sciences
  Read Live
• Pharma Commerce: Machine Learning Finds Purpose in Commercial Life Sciences
  Read Live
• Medical Marketing & Media: How These Companies are Leveraging Data to Engage A-List HCPs
  Read Live
• MedAdNews: The New (Augmented) Reality in Life Sciences
  Read Live
• RAPS Regulatory Focus: BMS and Halozyme Journey to RIM Transformation
  Read Live
• DIA Global Forum
  Read Live
• Clinical Leader
  Read Live
• Outsourcing Pharma
  Read Live